CRABP2 and esophageal squamous cell carcinoma: As a result, in the study, we firstly evaluated the expression of CRABP2 at both mRNA and protein levels in clinical ESCC tissues (T) and paired adjacent normal tissues (N), using the quantitative real-time PCR (qRT-PCR) and immunohistochemistry assays (IHC), respectively.